Clinical evaluation of TEG6s PlateletMapping assay during cardiopulmonary bypass : A prospective observational study
Not Applicable
- Conditions
- 1.Patients undergoing cardiovascular surgery using cardiopulmonary bypass
- Registration Number
- JPRN-UMIN000034731
- Lead Sponsor
- Department of Anesthesiology, Tokyo Medical and Dental University, Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who refuse obtainment of informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Correlation between plasma fibrinogen concentration and MAFibrin in Platelet Mapping assay. 2.Correlation between platelet count and MAADP, MAThrombin
- Secondary Outcome Measures
Name Time Method 1)Correlation between platelet inhibition (MAThrombin - MAADP) and medication history, duration of cardiopulmonary bypass 2)Comparing the data from the samples drawn at the end of the aortic cross clamping with those from the samples drawn after protamine administration